Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 945K 896K 809K 1.52M 103M 1.54M 10.72M 4.12M 52.63M 4.03M 3.94M 169M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 728K 690K 623K 1.17M 79.26M 1.19M 8.25M 3.18M 40.52M 3.1M 3.04M 130M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day+0.14%
1 week-0.14%
Current month-0.14%
1 month-0.14%
6 months+40.00%
Current year+133.33%
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 2019-06-25
Director TitleAgeSince
Director/Board Member 64 2002-12-31
Director/Board Member 84 2004-12-31
Director/Board Member - 2018-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-0.14%+600.00%-96.82% 26.4K
+0.77%+2.46%-0.97%+62.44% 3,779B
+0.04%-2.47%+2.54%+1,069.06% 449B
-0.36%-5.02%-51.18%+29.63% 418B
+2.29%+1.02%+95.12%+238.94% 318B
+0.77%+0.86%+115.95%+532.69% 270B
+0.18%+1.83%-17.69%+51.16% 242B
+3.13%-4.81%-27.19%+19.87% 134B
+1.59%+0.01%+112.61%+204.64% 129B
-4.98%-7.87%-59.58%+626.80% 102B
Average +0.51%+0.33%+76.96%+273.84% 584.17B
Weighted average by Cap. +0.39%+1.73%+6.52%+180.39%

Financials

2015 2016
Net sales 4.22M 3.72M 3.52M 3.18M 5.99M 405M 6.07M 42.15M 16.22M 207M 15.85M 15.51M 663M 3.04M 2.68M 2.54M 2.29M 4.32M 292M 4.38M 30.4M 11.7M 149M 11.43M 11.18M 479M
Net income 151K 133K 126K 114K 214K 14.48M 217K 1.51M 580K 7.4M 567K 555K 23.73M -344K -303K -287K -259K -488K -32.98M -495K -3.43M -1.32M -16.86M -1.29M -1.26M -54.06M
Net Debt -340K -299K -284K -256K -483K -32.6M -489K -3.39M -1.31M -16.67M -1.28M -1.25M -53.43M -247K -218K -206K -186K -351K -23.68M -355K -2.47M -949K -12.11M -927K -907K -38.82M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NMXS Stock